Will mosaic vaccine immunogens expand immune response breadth to rival HIV-1 strain diversity?

Author： Day Tracey A Morgan Cecilia A Kublin James G

ISSN： 2041-6792

Source： Clinical Investigation, Vol.3, Iss.5, 2013-05, pp. : 413-415

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A vaccine for leukemia: one step closer? Cure-oriented WT1 peptide vaccination therapy is being developed

By Oka Yoshihiro

Clinical Investigation, Vol. 3, Iss. 5, 2013-05 ,pp. : 421-424

Future Science

Access to resources Recommend Favorite

Human papillomavirus (HPV) vaccine policy and evidence-based medicine: Are they at odds?

By Tomljenovic Lucija Shaw Christopher A.

Annals of Medicine, Vol. 45, Iss. 2, 2013-03 ,pp. : 182-193

Informa Healthcare

Access to resources Recommend Favorite

Five‐year follow‐up of immune response after one or two doses of inactivated hepatitis A vaccine given at 1 year of age in the Mendoza Province of Argentina

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. 4, 2015-04 ,pp. : 453-458

John Wiley & Sons Inc

Access to resources Recommend Favorite

Inflammation and Colorectal Cancer: Does Aspirin Affect the Interaction between Cancer and Immune Cells?

By Bergman Michael

Inflammation, Vol. 34, Iss. 1, 2011-02 ,pp. : 22-28

Springer Publishing Company

Access to resources Recommend Favorite

Characterization of the Immune Response to Trivalent Influenza Vaccine in Elderly Men

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 35, Iss. 7, 1987-07 ,pp. : 609-615

John Wiley & Sons Inc

Access to resources Recommend Favorite